LAUREN MCMILLAN: Open Payments
NPI 1568750636 · WAYNESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 13 payments from 7 companies in 2025. Trend: 2023 $278 · 2024 $204 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $110 |
| Novo Nordisk Inc | 3 | $44 |
| Lilly USA, LLC | 1 | $25 |
| Boston Scientific Corporation | 1 | $22 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Veozah, Wegovy, MOUNJARO, WaveWriter Alpha Prime 16, NEFFY, FARXIGA, SHINGRIX, Ozempic.
Industry payments across GA — which companies pay providers there.
